Jason A. Keyes, Director of Actuate Therapeutics ACTU, has filed 0 purchases and 4 sales on the open market. The latest trade was on 05/21.

JK

JK

Jason A. Keyes

Director

Company

Actuate Therapeutics ACTU

First filing

23/01/04

Trades

25 trades

Buys / sales

0 / 4

12-month net buying

No record

Last trade

05/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
EquilliumEQ	Open-market sale10b5-1 plan	25/01/23	25/01/24	10,000 sh	$0.65	$6,500	−21.0%
EquilliumEQ	Open-market sale10b5-1 plan	24/11/14	24/11/15	10,000 sh	$0.70	$7,000	−17.3%
EquilliumEQ	Open-market sale10b5-1 plan	24/09/26	24/09/27	10,000 sh	$0.81	$8,100	−14.8%
EquilliumEQ	Open-market sale10b5-1 plan	24/07/16	24/07/18	10,000 sh	$0.87	$8,700	−12.9%